Results 241 to 250 of about 5,782 (258)

Mechanistic prediction of first-in-human dose for bispecific CD3/EpCAM T-cell engager antibody M701, using an integrated PK/PD modeling method

European Journal of Pharmaceutical Sciences, 2021
Junsheng Xue, Dongyang Liu
exaly  

T-cell engagers in rheumatology

Best Practice & Research Clinical Rheumatology
Alberto Nordmann-Gomes, Leila Khalili, Stephen Wax, Anca Askanase   +3 more
openaire   +1 more source

A PD-L1xCD3 bispecific nanobody as a novel T-cell engager in treating PD-L1 overexpression melanoma

Molecular Immunology, 2023
Baizhi Li, Baihui Shan, Fuqiu Li
exaly  

Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus Monkeys

Toxicological Sciences, 2022
Tod A Harper, Hervé Lebrec, Olivier Nolan-Stevaux   +2 more
exaly  

In situ subcutaneously injectable thermosensitive PEG-PLGA diblock and PLGA-PEG-PLGA triblock copolymer composite as sustained delivery of bispecific anti-CD3 scFv T-cell/anti-EGFR Fab Engager (BiTEE)

Biomaterials, 2021
Han Lin, Kuo-Hsiang Chuang, Ming-Thau Sheu   +2 more
exaly  

The expanding success of T cell-engaging bispecific antibodies

Nature Cancer, 2023
openaire   +2 more sources

Characterization of Bispecific T-cell Engager (BiTE®) Antibodies with a High-Capacity T-cell Dependent Cellular Cytotoxicity (TDCC) Assay

SLAS Discovery, 2015
Angus M Sinclair
exaly  

GPRC5D-targeted bispecific bolsters T-cell-engager pipeline

Nature Reviews Drug Discovery, 2023
exaly  

COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors

MAbs, 2020
exaly  

Tumor flare with T-cell-engaging bispecific antibodies

Leukemia & Lymphoma
Carmelo Carlo-Stella, Michael J. Dickinson, Gloria Iacoboni, Cecilia Carpio, Natalie Dimier, Martin Weisser, Antonia Kwan, Cristiano Ferlini   +7 more
openaire   +2 more sources